PillRx only · Powder · Respiratory (Inhalation)
Umeclidinium Bromide And Vilanterol Trifenatate
Brands: Anoro Ellipta · Umeclidinium Bromide + Vilanterol Trifenatate
2 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US2 NDCs
2 active makers
2 active makers
UKComing
soon
soon
CAComing
soon
soon
AUComing
soon
soon
EUComing
soon
soon
ATC—
RxCUI (US)1487514
US makers2 labelers
Packages3
DEA / ScheduleNone
US acquisition costNADAC · per unit
Average across 3 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.
$6.917
Latest avg · Jul 22, 2026
-0%
Since Dec 17, 2025
2
Active US suppliers
100%
Top-2 supplier share*
Medicaid dispensing volumeSDUD · per quarter
Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.
123K
Rx · 2026 Q1
8.0M
Units dispensed
-15%
Rx vs. year ago
5
Quarters · since 2025 Q1
Who makes it2 active · 0 exited
US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.
| Labeler | Type | Packages | Status |
|---|---|---|---|
| GlaxoSmithKline LLC | unknown | 2 | SUPPLYING |
| Prasco Laboratories | unknown | 1 | SUPPLYING |
Regulatory & supply eventsFDA · US
Shortages, recalls, and registration changes attached to this drug concept.
- Dec 12, 2023RECALLRecall (Class III): ANORO ELLIPTA (umeclidinium and vilanterol inhalation powder) 62.5 mcg/25mcg. 1 inhaler contains 30 doses (60 blisters…
Failed Release Testing: Coarse Particle Mass for umeclidinium Out of Specification — Recalling firm: GlaxoSmithKline LLC — Distributed Nationwide in the USA and Puerto Rico.